Ranitidine Recall: Time to know that other drugs do not have NDMA
Dr KK Aggarwal, 03 October 2019
remove_red_eye 2838 Views
#Multispeciality
Coronavirus Live Count Map India
remove_red_eye 2838 Views
COVID-19 Vaccine Updates
Coronavirus Protocols
#Multispeciality
On September 13, 2019, the US FDA announced that preliminary tests found low levels of N-nitrosodimethylamine (NDMA) in ranitidine, a heartburn medication. Novartis (through its generic division, Sandoz) and Apotex announced that they were recalling all of their generic ranitidine products sold in the US. GSK has also recalled its ranitidine medication sold in global markets including in India.Ranitidine is an H2 (or histamine-2) blocker and is commonly used to relieve and prevent heartburn...
Create Account
Login Now
To read the complete article ,
create a free account.
Sign Up
to instantly read 30000+ free Articles & 1000+ Case Studies
Already registered?
.jpg)
Very relevent as ranitidine is used so widely including in neonates also. Clear guidelines should be given as dvisory from the Govt in this case so that physicians are not exposed to future mefico legal problems